Analysts Are Bullish on Top Healthcare Stocks: Third Harmonic Bio, Inc. (THRD), Treace Medical Concepts (TMCI)
TipRanksNov 9, 2023 21:21 ET
Morgan Stanley Maintains Equal-Weight on Third Harmonic Bio, Raises Price Target to $7
BenzingaAug 11, 2023 09:16 ET
Third Harmonic Bio Analyst Ratings
BenzingaAug 11, 2023 09:15 ET
Analysts Offer Insights on Healthcare Companies: Third Harmonic Bio, Inc. (THRD) and Verve Therapeutics (VERV)
TipRanksAug 10, 2023 15:50 ET
LifeSci Capital Upgrades Third Harmonic Bio, Inc. (THRD) to a Buy
TipRanksJul 25, 2023 17:15 ET
LifeSci Capital Sticks to Its Hold Rating for Third Harmonic Bio, Inc. (THRD)
TipRanksMay 11, 2023 19:25 ET
LifeSci Capital Keeps Their Hold Rating on Third Harmonic Bio, Inc. (THRD)
TipRanksDec 19, 2022 11:30 ET
Third Harmonic Bio Analyst Ratings
Benzinga Analyst RatingsDec 16, 2022 06:03 ET
Jefferies Downgrades Third Harmonic Bio to Hold, Lowers Price Target to $3.6
Benzinga Real-time NewsDec 16, 2022 06:02 ET
Third Harmonic Bio, Inc. (THRD) Has a New Rating From Jefferies
TipRanksOct 10, 2022 12:50 ET
Morgan Stanley Starts Third Harmonic Bio at Overweight With $34 Price Target
MT NewswiresOct 10, 2022 07:08 ET
Third Harmonic Bio Analyst Ratings
Benzinga Analyst RatingsOct 10, 2022 06:14 ET
No Data
No Data